A Castegna

First name:
A
Last name:
Castegna
Castegna, A., Klein, J. B., Lynn, B., Markesbery, W. R., & Butterfield, D. A. (2003). Proteomic identification of nitrated proteins in Alzheimer's disease brain. Journal Of Neurochemistry, 85(6), 1394-401. https://doi.org/10.1046/j.1471-4159.2003.01786.x
View
Butterfield, D. A., Favia, M., Spera, I., Campanella, A., Lanza, M., & Castegna, A. (2022). Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases. Molecules (Basel, Switzerland), 27(3). https://doi.org/10.3390/molecules27030951 (Original work published 2022)
View
Palmieri, E. M., Menga, A., Lebrun, A., Hooper, D. C., Butterfield, D. A., Mazzone, M., & Castegna, A. (2017). Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells. Antioxidants & Redox Signaling, 26(8), 351-363. https://doi.org/10.1089/ars.2016.6715 (Original work published 2017)
View
Butterfield, D. A., Palmieri, E. M., & Castegna, A. Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins. Expert Review Of Proteomics, 13(3), 259-74. https://doi.org/10.1586/14789450.2016.1149470 (Original work published 2016)
View
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001). Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends In Molecular Medicine, 7(12), 548-54. https://doi.org/10.1016/s1471-4914(01)02173-6
View
Castegna, A., Aksenov, M., Aksenova, M., Klein, J. B., Pierce, W. M., Booze, R., et al. (2002). Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radical Biology & Medicine, 33(4), 562-71. https://doi.org/10.1016/s0891-5849(02)00914-0 (Original work published 2002)
View
Butterfield, D. A., Castegna, A., Drake, J., & Scapagnini, G. (2002). Vitamin E and neurodegenerative disorders associated with oxidative stress. Nutritional Neuroscience, 5(4), 229-39. https://doi.org/10.1080/10284150290028954
View
Castegna, A., Aksenov, M., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., et al. (2002). Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. Journal Of Neurochemistry, 82(6), 1524-32. https://doi.org/10.1046/j.1471-4159.2002.01103.x
View
Butterfield, D. A., Castegna, A., Lauderback, C. M., & Drake, J. (1969). Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiology Of Aging, 23(5), 655-64. https://doi.org/10.1016/s0197-4580(01)00340-2 (Original work published 1969)
View
Lauderback, C. M., Drake, J., Zhou, D., Hackett, J. M., Castegna, A., Kanski, J., et al. (2003). Derivatives of xanthic acid are novel antioxidants: application to synaptosomes. Free Radical Research, 37(4), 355-65. https://doi.org/10.1080/1071576021000040664
View